Welcome to the Moodbuster study website:
If you are feeling low and live in the UK, you may be interested in taking part in our study to evaluate Moodbuster, an online programme that can help to improve your mood and wellbeing.
Why should I participate?
Your participation will help us to evaluate whether this online tool could offer people relief from their symptoms and serve as part of a larger prevention programme for depression in the wider population.
What would taking part involve?
We want to test MoodBuster, a guided website and app that uses the principles of CBT (Cognitive Behavioural Therapy) for self-management of low mood. You will take part in the study in your own time from the comfort of your home.
Can I participate?
To participate, you must be able to answer yes to the following statements:
- "I live in the UK,"
- "I am aged between 18 and 65."
- "I own a laptop computer and an iPhone/Android smartphone."
- "I have not been diagnosed with a mental health condition in the past."
- "I am not currently receiving therapy or begun taking antidepressant medication in the past six weeks."
I would like to participate
Please get in touch at [email protected] or fill in the form below.
What is e-mental health?
What is Moodbuster?
Moodbuster is a self-led, online programme and app that has been designed to support individuals experiencing mild to moderate symptoms of depression.
The version that we are currently trialling uses CBT-based support in areas of psychoeducation, behavioural activation, exercise, problem solving and staying well.
More about this project and our team
This study is part of eMEN, an e-mental health project funded by the Interreg North West Europe Innovation Programme. Over the next three years until 2020, eMEN will examine the development, quality and availability of digital mental health (e-mental health) across six countries within the European Union (Netherlands [lead partner], United Kingdom, Ireland, France, Germany, and Belgium).
The Mental Health Foundation research team are working with our partners at the Vrije Universiteit Amsterdam and the Academic Medical Centre, Amsterdam, to develop and test Moodbuster. We are running this study in the UK in collaboration with the University of Manchester.